TFRC and neoplasm: Using whole slides of non-cultured patient tumor tissue, our results supported this showing that TfR1, FTH, and FTL were co-expressed to some extent with the stem cell marker CD133, and we furthermore found that TfR1 was elevated in GBMs and associated with short survival in astrocytomas.